drugset / Trial / NCT00004059
Fluorouracil Plus UCN-01 in Treating Patients With Advanced or Refractory Solid Tumors
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. UCN-01 may increase the effectiveness of a chemotherapy drug by making tumor cells more sensitive to the drug. PURPOSE: Phase I trial to study the effectiveness of fluorouracil plus UCN-01 in treating patients who have advanced or refractory solid tumors.
Timeline
- Start
- 1999-07
- Primary completion
- 2002-09
- Completion
- 2002-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | UCN-01 | Small molecule | — | Intravenous |
| Subject | fluorouracil | Small molecule | — | Intravenous |